Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/07/2005EP1601641A2 Substituted anilide ligands for the thyroid receptor
12/07/2005EP1601380A1 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
12/07/2005EP1601379A1 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
12/07/2005EP1601368A2 Methods and compositions for treatment of viral diseases
12/07/2005EP1601367A2 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions
12/07/2005EP1601365A2 Prophylactic treatment of uv-induced epidermal neoplasia
12/07/2005EP1601364A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds
12/07/2005EP1601363A2 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
12/07/2005EP1601362A2 Use of diazoxide in the treatment of ischemia retinae
12/07/2005EP1601361A2 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy
12/07/2005EP1601359A1 Liquid pharmaceutical formulations of palonosetron
12/07/2005EP1601356A1 Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
12/07/2005EP1601355A2 Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of ip-10 mediated diseases
12/07/2005EP1601353A2 Prevention of surgical adhesions using selective cox-2 inhibitors
12/07/2005EP1601352A2 Combined use of a fibrate and orlistat for the treatment of obesity
12/07/2005EP1601351A1 Use of ep2 selective receptor agonists in medical treatment
12/07/2005EP1601350A1 Titration dosing regimen for controlled release tramadol
12/07/2005EP1601349A1 Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament
12/07/2005EP1601348A2 Compositions and methods with enhanced therapeutic activity
12/07/2005EP1601346A2 Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method
12/07/2005EP1601340A2 Regulation of mammalian hair growth
12/07/2005EP1601339A2 Skin peeling composition and method
12/07/2005EP1601333A2 Novel insertion sites in pox vectors
12/07/2005EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them
12/07/2005EP1601328A2 Polyvalent immunogen
12/07/2005EP1601325A2 Antisense oligonucleotides that inhibit expression of hif-1
12/07/2005EP1601324A2 Hemostatic compositions and methods
12/07/2005EP1601251A2 Compounds for the treatment of metabolic disorders
12/07/2005EP1601249A1 1-n-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases
12/07/2005EP1578983A3 Methods for regulating co-stimulatory molecule expression with reactive oxygen
12/07/2005EP1525198B1 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
12/07/2005EP1501823B1 New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
12/07/2005EP1499607B1 4-(piperidyl- and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1458715B1 Novel compounds
12/07/2005EP1439840B1 Monobactam antibacterial compounds and methods of use thereof
12/07/2005EP1425381A4 Emu-based formulations for wound treatment related application information
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1389207B1 Polymorphic and other crystalline forms of cis-ftc
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP1368309B1 Thiol-modified hyaluronan
12/07/2005EP1362593B1 Cytidine-phosphocholine for the treatment of diabetic neuropathy
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1337228B1 Compositions for removing human cerumen
12/07/2005EP1326608B1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers
12/07/2005EP1322305B1 Use of r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature
12/07/2005EP1317187B1 Feedstuff or a feedstuff additive used as a performance promoter or as an appetite promoter for domestic animals
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1307107B1 Oil/fat composition
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1301191B1 Potent immunostimulants from microalgae
12/07/2005EP1296987B1 Compounds for treating impaired fundic relaxation
12/07/2005EP1294717B1 A thiazine oxazolidinone
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1272059B1 Method of producing oily suspensions of water-soluble vitamins
12/07/2005EP1270584B1 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
12/07/2005EP1267806B1 Use of cosmetic and pharmaceutical compositions comprising 2-decarboxy-2-phosphinico derivatives of prostaglandins
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP1246828B1 Benzosulfones with calcium antagonist activity
12/07/2005EP1221852B1 Therapeutic use of antimicrobial compositions comprising a benzoic acid analog and a metal salt
12/07/2005EP1217001B1 Quinuclidine compounds and drugs containing the same as the active ingredient
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1212056B1 Methods and compositions for bisubstrate inhibitors of acetyltransferases
12/07/2005EP1203583B1 Remedies for arthrosis deformans
12/07/2005EP1196129B1 Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1169303B1 Aryl-chloroalkyl ureas
12/07/2005EP1165094B1 Dispersible macrolide compounds and method for the production thereof
12/07/2005EP1161241B1 Stable pharmaceutical application form for paroxetin anhydrate
12/07/2005EP1156802B1 Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine
12/07/2005EP1155019B1 Substituted porphyrins and their therapeutic use
12/07/2005EP1151751B1 Cataplasms containing vitamin c or its derivative
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1124548B1 Compositions for the treatment and prevention of cardiovascular diseases
12/07/2005EP1117412B1 Compositions containing diphosphonic acids
12/07/2005EP1097138B1 Pharmaceutical compositions comprising 2-quinolones
12/07/2005EP1091733B1 (-)-pseudoephedrine as a sympathomimetic drug
12/07/2005EP1089727B1 Liposomal formulations of busulphan
12/07/2005EP1079809B1 Enteric coated pharmaceutical composition and method of manufacturing
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1073657B1 Imidazo pyridine derivatives which inhibit gastric acid secretion
12/07/2005EP1071412B1 Use of quinolinate for treating gastrointestinal disorders
12/07/2005EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders
12/07/2005EP1064263B1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection
12/07/2005EP1049466B1 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
12/07/2005EP1038524B1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
12/07/2005EP1030567B9 System for dialysis and shock treatment
12/07/2005EP1017394B1 Cyclin dependent kinase inhibiting purine derivatives
12/07/2005EP1014967B1 Use of zinc salts of conjugated linoleic acids to treat skin disorders
12/07/2005EP1011658B1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
12/07/2005EP0988059B1 Human quinone reductase 2 conjugates for adept and gdept
12/07/2005EP0981523B1 Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005EP0949920B1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
12/07/2005EP0944312B1 Compositions and methods for stimulating bone growth
12/07/2005EP0831812B1 Methods and compositions for stimulating neurite growth
12/07/2005EP0794794B1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
1 ... 4444 4445 4446 4447 4448 4449 4450 4451 4452 4453 4454 4455 4456 4457 4458 4459 4460 4461 4462 4463 4464 ... 7860